1 Percent: Antibiotic Research Is Dying In The UK
Thursday, July 24, 2014 - 21:10
in Mathematics & Economics
Pharmaceutical companies are in a tough position; they are highly regulated, trials are expensive, new products fail most of the time, and if they are successful, everyone complains the cost is too high while the company tries to make money before it goes generic. In the UK, the company with the best antibiotic pipeline in the world, AstraZeneca, is trying to sell that business, because they don't think they will ever make money at it given current restrictions. read more